British bootmaker Dr Martens stuck to its fiscal 2027 outlook on Wednesday, citing encouraging wholesale demand in its largest market, the United States.
Trading has been in line with expectations since the start of its financial year in April, the company said. Dr Martens also reported that Japan and South Korea were performing well, and European markets were in line with expectations despite a challenging consumer backdrop.
In May, Dr Martens reported a revenue decline from the Europe, Middle East, and Africa region as the economic fallout from the Iran war weighed on consumer spending. The company is expected to report an adjusted pretax profit of £68 million ($91.21 million) for fiscal 2027, according to a company-compiled consensus.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
